|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 314.50 EUR | -1.41% |
|
-3.38% | -0.63% |
| Apr. 16 | VIRBAC : Decent Q1; Clarity on US tariff exposure was a key takeaway |  |
| Apr. 16 | VIRBAC : Stifel still buying after Q1 results | CF |
| Capitalization | 2.67B 3.09B 2.52B 2.28B 4.21B 265B 4.74B 29.22B 11.41B 122B 11.6B 11.36B 444B | P/E ratio 2025 * |
16.8x | P/E ratio 2026 * | 15x |
|---|---|---|---|---|---|
| Enterprise value | 2.78B 3.21B 2.61B 2.36B 4.37B 275B 4.93B 30.36B 11.85B 126B 12.05B 11.8B 462B | EV / Sales 2025 * |
1.87x | EV / Sales 2026 * | 1.73x |
| Free-Float |
47.73% | Yield 2025 * |
0.5% | Yield 2026 * | 0.55% |
More valuation ratios
* Estimated data
More news
Last Transcript: Virbac
More recommendations
More press releases
More news
| 1 day | -1.41% | ||
| 1 week | -3.38% | ||
| Current month | -5.56% | ||
| 1 month | +2.14% | ||
| 3 months | +3.62% | ||
| 6 months | -2.48% | ||
| Current year | -0.63% |
| 1 week | 313.5 |  | 328.5 |
| 1 month | 301.5 | | 335.5 |
| Current year | 249.7 | | 335.5 |
| 1 year | 249.7 | | 400 |
| 3 years | 215 | | 400 |
| 5 years | 176.4 | | 448.5 |
| 10 years | 102.1 | | 448.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Habib Ramdani
CEO | Chief Executive Officer | 49 | 2024-09-26 |
Sophie Favini
COO | Chief Operating Officer | - | 2023-06-30 |
| Chief Tech/Sci/R&D Officer | - | 2020-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 60 | 2006-03-31 | |
Philippe Capron
BRD | Director/Board Member | 66 | 2010-07-27 |
| Director/Board Member | 64 | 2017-09-04 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.41% | -3.38% | -8.31% | -6.81% | 3.09B | ||
| +1.50% | +0.12% | -4.00% | +4.54% | 75.16B | ||
| -0.70% | +5.51% | -20.75% | -36.37% | 7.04B | ||
| -0.10% | +1.15% | -2.43% | -3.21% | 3.61B | ||
| -3.92% | -2.48% | +18.63% | -24.50% | 2.31B | ||
| -0.94% | -5.58% | +44.04% | +27.32% | 1.34B | ||
| -2.87% | -3.77% | +5.00% | -23.71% | 1.07B | ||
| +0.43% | +1.29% | -14.70% | -41.44% | 1.01B | ||
| -0.55% | -0.14% | -28.92% | -35.95% | 995M | ||
| +0.49% | +2.60% | +37.85% | +31.28% | 993M | ||
| Average | -0.81% | +0.32% | +2.64% | -10.89% | 9.66B | |
| Weighted average by Cap. | +0.93% | +0.37% | -3.93% | -0.41% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.48B 1.72B 1.4B 1.26B 2.34B 147B 2.63B 16.22B 6.33B 67.53B 6.44B 6.3B 247B | 1.56B 1.8B 1.47B 1.33B 2.46B 155B 2.77B 17.05B 6.66B 71B 6.77B 6.63B 259B |
| Net income | 162M 187M 152M 138M 255M 16.02B 287M 1.77B 690M 7.36B 702M 687M 26.89B | 179M 207M 169M 153M 282M 17.77B 318M 1.96B 765M 8.16B 778M 762M 29.82B |
| Net Debt | 104M 120M 97.97M 88.65M 164M 10.31B 185M 1.14B 444M 4.74B 452M 442M 17.31B | 18.13M 20.98M 17.07M 15.44M 28.57M 1.8B 32.18M 198M 77.42M 826M 78.71M 77.05M 3.02B |
More financial data
* Estimated data
Employees
6,365
Sector
Pharmaceuticals
Calendar
Jun. 18
- Annual General Meeting
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-13 | 314.50 € | -1.41% | 171 |
| 25-06-12 | 319.00 € | -0.16% | 3,573 |
| 25-06-11 | 319.50 € | -1.39% | 3,883 |
| 25-06-10 | 324.00 € | -0.61% | 1,836 |
| 25-06-09 | 326.00 € | +0.15% | 1,556 |
Real-time Euronext Paris, June 13, 2025 at 03:00 am EDT
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
319.00EUR
Average target price
386.83EUR
Spread / Average Target
+21.26%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VIRP Stock
Select your edition
All financial news and data tailored to specific country editions
